|
250+ Individual Companies in Attendance
(over 550 individual executives presently registered)
|
| 30 Technology |
| 4Tissue |
| 9xchange |
| a:head bio AG |
| AATec Medical GmbH |
| AaviGen GmbH |
| AbolerIS Pharma |
| Acorai |
| Acousia Therapeutics |
| Actimed Therapeutics |
| ActionAid |
| Actithera Inc. |
| ADcendo |
| Adocia |
| Adrenomed |
| Advanced Medical Balloons GmbH |
| Alchemab |
| Alentis Therapeutics |
| Aliform |
| AlignedBio AB |
| Allegro NV |
| Alligator Bioscience AB |
| ALSA Ventures |
| Alveron Pharma |
| AM-Pharma |
| Ambrose Healthcare |
| Amolyt Pharma |
| Anavo Therapeutics |
| aNeuroTech |
| Anocca AB |
| Aperture Therapeutics |
| Apollo Therapeutics |
| Aqilion AB |
| Arch Venture Partners |
| Archangel Acta |
| Ariceum Therapeutics |
| Arix Bioscience |
| ARTBIO INC. |
| ASABYS PARTNERS |
| Astex Pharmaceuticals (UK) |
| Astraveus |
| Atheneos Ventures LLC |
| Autolus Therapeutics |
| Baker McKenzie |
| BenevolentAI |
| Bicycle Therapeutics |
| BioArctic |
| Biofidelity |
| BioLizard |
| Biomedical Bonding AB |
| Bloomberg |
| BPGBio |
| Brainomix Limited |
| Brenus Pharma |
| British Patient Capital |
| Brookstreet Equity |
| Bulnes Capital |
| C4X Discovery |
| Calliditas Therapeutics |
| Cambridge Innovation Capital |
| CancerAppy |
| Candesic |
| Canopy Immuno Therapeutics |
| Cantargia |
| Cape Investment Partners |
| Cascara |
| Catalym GmbH |
| Cellectar Biosciences Inc. |
| Cellprothera |
| Cellsway |
| CIS BIOPHARMA AG |
| Complement Therapeutics |
| Comprevie |
| Confo Therapeutics |
| Cooley |
| Corwave |
| Coulter Partners |
| Cradle |
| Crescendo Biologics Limited |
| CS Medica A/S |
| Cumulus Oncology LTD |
| Cutanos |
| Cydar Medical |
| Danforth Advisors |
| Dark Blue Therapeutics |
| Debiopharm |
| Deep Science Ventures |
| Delin Ventures |
| Devyser Diagnostics AB |
| DFIN |
| Droege Group |
| Duke Street Bio Ltd. |
| Eczacibasi Pharmaceuticals and Healthcare Investments |
| Engimmune Therapeutics |
| Epidarex Capital |
| Fibrocor Therapeutics |
| Finn Therapeutics Ltd. |
| Forbion |
| FTI Consulting |
| Galimedix Therapeutics |
| Ganymed Robotics |
| Gleamer.ai |
| GlobalData |
| Greywolf Therapeutics |
| Grünenthal |
| GSK |
| Guggenheim Partners |
| Heidelberg Pharma AG |
| Hemab |
| HERVOLUTION Therapeutics |
| HGF Limited |
| HighCape Capital |
| Hitachi Ventures |
| hVIVO plc |
| Hypervision Surgical |
| Hyphen Communities / JL Development |
| ICG AM |
| Iconovo Pharma AB |
| ICR Consilium |
| Imperial College |
| Implandata Ophthalmic Products |
| Implant Preservation Devices B.V. |
| InfanDx AG |
| Informa Connect |
| INGEN HOUSZ |
| InnoMedica |
| Insmed Innovation UK Limited |
| Inveready Asset Management |
| Ipsen |
| Istesso Ltd |
| Jacksons Accountants |
| Keyron |
| King’s College London |
| KNect365 Life Sciences |
| Lean Life Science Limited |
| Leerink Partners |
| Leucid Bio |
| Lifespin GmbH |
| LIfT BioSciences |
| Lilly |
| Liva Health |
| Lonza AG |
| M Ventures |
| MAbSilico |
| Macomics Ltd |
| Matisse Pharmaceuticals B.V. |
| MC Services |
| McKinsey & Company |
| Medetia |
| Medherant |
| Medistrava Consulting |
| MEDKAP Investor Association |
| Memo Therapeutics |
| Mendus |
| Mercia Ventures |
| Merck HealthCare KGaA |
| Merck Serono Ltd. |
| Microsynetics |
| Mills & Reeve LLP |
| Mimetas |
| MinervaX |
| Mintz |
| Mithra Pharmaceuticals |
| Mitotech S.A. |
| Modiblast Pharma GmbH |
| Mosaic Therapeutics |
| MSD |
| MUVON Therapeutics |
| MYoroface AB |
| Nanobiotix |
| Nanoligent |
| NanoSyrinx |
| Neurocentrx |
| New Growth Advisors |
| NewAmsterdam Pharma |
| NewCo |
| Novartis International AG |
| Novartis Venture Fund |
| Novo Holdings |
| Novo Nordisk |
| Nuage Therapeutics S.L. |
| Nucleome Therapeutics |
| Numis |
| Ochre Bio, Inc. |
| Octopus Ventures |
| Oculis |
| OMass Therapeutics |
| Oncodesign Precision Medicine |
| Optimum Strategic Communications |
| Orion Biotechnology |
| Our Future Health |
| Owlstone Medical |
| Oxford Science Enterprises |
| OxSonics Therapeutics |
| Pacertool AS |
| partneringONE |
| Pear Bio |
| Pharvaris |
| Pinpoint Molecular |
| Pledge Therapeutics |
| PLEXaa Ltd |
| Poolbeg Pharma plc |
| Precirix |
| PrecisionLife |
| Prokarium |
| Quell Therapeutics |
| Qurin PCR BV |
| Raya Therapeutic, Inc. |
| Re-Vana Therapeutics |
| Redeye AB |
| Reponex Pharmaceuticals AS, Pharma Equity Group AS |
| RHA Communications |
| RISING |
| RV Invest |
| Sania Therapeutics |
| Scenic Biotech |
| Seamless Therapeutics |
| Senisca |
| Sensorion |
| Seqera |
| Sequana Medical |
| SERB Pharmaceuticals |
| Sibylla Biotech |
| Sirgartan Therapeutics |
| Sixfold Bioscience |
| Sixth Element Capital LLP |
| Smart Immune |
| Sobi, Inc. |
| Sofinnova Partners |
| Sound Bioventures |
| SpliceBio |
| SR One |
| SR One Capital Management, LP |
| Srotas Health Ltd |
| STENTiT |
| Sterna Biologicals |
| Stroma Medical |
| Synaffix BV |
| Syneos Health |
| T-Therapeutics |
| Tada Group AB |
| Tagworks Pharma |
| Teitur Trophics |
| Tethis SpA |
| TILT Biotherapeutics |
| TISSIUM |
| Trill Impact |
| Truffle Capital |
| Tubulis GmbH |
| Ultimovacs |
| Vaccitech Limited |
| Van Lanschot Kempen |
| VasoDynamics Ltd |
| Verge Healthtech Fund |
| Vicore Pharma |
| Virometix |
| WG Partners |
| XNK Therapeutics |
| Zura Bio |
| Zyme Communications |
